Cost‐effectiveness of population‐based, community, workplace and individual policies for diabetes prevention in the UK
Open Access
- 18 April 2017
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 34 (8) , 1136-1144
Abstract
Aim: To analyse the cost‐effectiveness of different interventions for Type 2 diabetes prevention within a common framework.Methods: A micro‐simulation model was developed to evaluate the cost‐effectiveness of a range of diabetes prevention interventions including: (1) soft drinks taxation; (2) retail policy in socially deprived areas; (3) workplace intervention; (4) community‐based intervention; and (5) screening and intensive lifestyle intervention in individuals with high diabetes risk. Within the model, individuals follow metabolic trajectories (for BMI, cholesterol, systolic blood pressure and glycaemia); individuals may develop diabetes, and some may exhibit complications of diabetes and related disorders, including cardiovascular disease, and eventually die. Lifetime healthcare costs, employment costs and quality‐adjusted life‐years are collected for each person.Results: All interventions generate more life‐years and lifetime quality‐adjusted life‐years and reduce healthcare spending compared with doing nothing. Screening and intensive lifestyle intervention generates greatest lifetime net benefit (£37) but is costly to implement. In comparison, soft drinks taxation or retail policy generate lower net benefit (£11 and £11) but are cost‐saving in a shorter time period, preferentially benefit individuals from deprived backgrounds and reduce employer costs.Conclusion: The model enables a wide range of diabetes prevention interventions to be evaluated according to cost‐effectiveness, employment and equity impacts over the short and long term, allowing decision‐makers to prioritize policies that maximize the expected benefits, as well as fulfilling other policy targets, such as addressing social inequalities.Keywords
Funding Information
- Public Health Research Programme (SPHR-SHF-PH1-MDP)
This publication has 27 references indexed in Scilit:
- A statistical model to describe longitudinal and correlated metabolic risk factors: the Whitehall II prospective studyJournal of Public Health, 2015
- Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional studyBMJ Open, 2014
- Modelling the Economics of Type 2 Diabetes Mellitus Prevention: A Literature Review of MethodsApplied Health Economics and Health Policy, 2014
- UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82Diabetologia, 2013
- Prediabetes: a high-risk state for diabetes developmentThe Lancet, 2012
- Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2BMJ, 2008
- Body Size and Risk of Colon and Rectal Cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC)JNCI: Journal of the National Cancer Institute, 2006
- Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC)International Journal of Cancer, 2004
- Profile for Estimating Risk of Heart FailureArchives of internal medicine (1960), 1999
- Cost-Effectiveness of the Primary Prevention of Non-Insulin Dependent Diabetes MellitusHealth Promotion International, 1998